***If Mr. Shawn Leon Play his Cards Right......Going Forward there is a Good Possibility that Ethema Health Care could become as good as his Competitors.....
<<Ethema Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders>>.
MASSIVELY undervalued compared to other companies GRST has only 2 competitors in the pure Behavioral Health sector.
ACHC
OTRK
Each of them trade on the NASDAQ and are worth billions
ACHC Market Cap = 4,75b
OTRK Market Cap = 1,5b
GRST Market Cap : 15m
***<<The market is exploding and GRST could become the 3rd major option in the $35 Billion addiction treatment industry>>
***The United States Substance Abuse Treatment Market size was estimated at: *USD 1,063.12 million in 2021; *USD 1,150.26 million in 2022; and is projected to grow at a CAGR 9.30% to reach *USD 1,812.92 million by 2027.
<<The CEO say: We will continue to focus on growth while improving our balance sheet.>>
-The Company growth is real and the elimination of variable rate debt is real. ***Please see Post #42737 & 42751 Reply from The CEO! =====================================================================
*** Shawn Leon did buy shares at 0.079 - He must feel Confident about the Future......
Purchase 2018-12-12 4:03 pm ETHEMA HEALTH Corp GRST Leon Shawn Edward CEO 10% Owner 28,350 $0.079 (Direct) View
The company does a good job cultivating and promoting the EBITDA number. When the Leonite June note defaults they can use that 24% to also help boost the EBITDA number. The use of that number is a bit of con. They never talk about revenue or real earnings for a reason. statements like "...growth will become our sole objective after repaying the debt...." are misleading as well. After repaying the debt?!? What year might that be? LOL
EBITDA = Net Income + Taxes + Interest Expense + Depreciation & Amortization
The Company’s ARIA subsidiary continued its growth and had a $712,839.00 EBITDA for the first nine months of the year.The Company’s wholly owned subsidiary, PB Billing LLC, which started operating in May 2022, had an EBITDA of $34,579.00 for the first 9 months of the year. Companywide EBITDA for the first nine months of the year was $898,920.00.
Mr. Shawn Leon, Company CEO, reported, “We had set a goal at the beginning of the year for our ARIA subsidiary to produce an EBITDA of $1,000,000 for calendar 2022. It looks like we are on track to make that goal and are very proud of our many associates and team members for helping us get there.
...We expect to substantially grow the EBITDA in 2023 as growth will become our sole objective after repaying the debt.”
News 
Market Data 
Discover 
